Related references
Note: Only part of the references are listed.Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan
Irene Marini et al.
HAEMATOLOGICA (2021)
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
Peter A. A. Norris et al.
HAEMATOLOGICA (2021)
Secondary ITP in adults
M. Michel et al.
REVUE DE MEDECINE INTERNE (2021)
Emerging Therapies in Immune Thrombocytopenia
Sylvain Audia et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients
Leendert Porcelijn et al.
HAEMATOLOGICA (2020)
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Adrian C. Newland et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Evaluating the effects of oseltamivir phosphate on platelet counts: a retrospective review
Hila Shaim et al.
PLATELETS (2020)
Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course
R. Castelli et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series
Matthieu Mahevas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
Thomas Rogier et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia: A systematic review and meta-analysis
S. N. Amini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
Tadeusz Robak et al.
BLOOD ADVANCES (2020)
Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia
Catherine M. Broome et al.
BLOOD (2020)
Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review
Yazan Migdady et al.
BLOOD ADVANCES (2020)
Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia
Richard Vollenberg et al.
HAEMATOLOGICA (2019)
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity
Jodi L. Karnell et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux
Samuel Deshayes et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
Michelle Rosenzwajg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Low-dose chidamide restores immune tolerance in ITP in mice and humans
Hong-yu Zhao et al.
BLOOD (2019)
M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
Leona E. Ling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content
Nuria Revilla et al.
PLATELETS (2019)
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura
Joan D. Beckman et al.
AMERICAN JOURNAL OF THERAPEUTICS (2018)
BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell-depletion context
Lan-Huong Thai et al.
BLOOD (2018)
Splenectomy for immune thrombocytopenia: down but not out
Shruti Chaturvedi et al.
BLOOD (2018)
Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art
Leendert Porcelijn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
Hanny Al-Samkari et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
Wojciech Jurczak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia
Sylvain Audia et al.
JOURNAL OF AUTOIMMUNITY (2018)
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
Peter Ulrichts et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
GPIIb/IIIa autoantibody predicts better rituximab response in ITP
Rui Feng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
Marianne Rorholt et al.
HAEMATOLOGICA (2017)
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia
Sylvain Audia et al.
JOURNAL OF AUTOIMMUNITY (2017)
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
Lili Tao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
Peter Kiessling et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
Marianne Rorholt et al.
HAEMATOLOGICA (2017)
Fcγ Receptor Heterogeneity in Leukocyte Functional Responses
Carlos Rosales
FRONTIERS IN IMMUNOLOGY (2017)
The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia
Donald M. Arnold et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia
M. Ebbo et al.
CLINICAL IMMUNOLOGY (2017)
Pathogenesis of immune thrombocytopenia
Sylvain Audia et al.
AUTOIMMUNITY REVIEWS (2017)
Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection
S. C. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia
S. Audia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
Yu Wei et al.
BLOOD (2016)
Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor
Ellinor I. B. Peerschke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
IVIG in autoimmune disease - Potential next generation biologics
Adrian W. Zuercher et al.
AUTOIMMUNITY REVIEWS (2016)
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia
Howard A. Liebman et al.
HAEMATOLOGICA (2016)
Long-term complications of splenectomy in adult immune thrombocytopenia
Lan-Huong Thai et al.
MEDICINE (2016)
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia
Howard A. Liebman et al.
HAEMATOLOGICA (2016)
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
Tomas Jose Gonzalez-Lopez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
June Li et al.
NATURE COMMUNICATIONS (2015)
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling
Renata Grozovsky et al.
NATURE MEDICINE (2015)
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2014)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Guillaume Moulis et al.
BLOOD (2014)
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Matthieu Mahevas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study
J. Peng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Interleukin-21: a double-edged sword with therapeutic potential
Rosanne Spolski et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Preferential splenic CD8+ T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Persistent Antigen and Germinal Center B Cells Sustain T Follicular Helper Cell Responses and Phenotype
Dirk Baumjohann et al.
IMMUNITY (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
CD4+CD25+Foxp3+ Regulatory T Cells in the Pathophysiology of Immune Thrombocytopenia
Tetsuya Nishimoto et al.
SEMINARS IN HEMATOLOGY (2013)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Intravenous immunoglobulin does not increase Fc?RIIB expression levels on monocytes in children with immune thrombocytopenia
M. Shimomura et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)
Abderrahim Najaoui et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
T-follicular helper cells survive as long-term memory cells
Jan P. Weber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia
Shujie Wang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia
Bob Olsson et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase
Shideh Kazerounian et al.
BLOOD (2011)
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2011)
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy
Leola Chow et al.
BLOOD (2010)
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
Weili Bao et al.
BLOOD (2010)
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
Ellinor I. B. Peerschke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study
Reimar W. Thomsen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura
Jingbo Zhang et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura
M. Kuwana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1
Bob Olsson et al.
BLOOD (2008)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
The effect of anti-CD40 ligand in immune thrombocytopenic purpura
Vivek L. Patel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura
Shuguang Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome
Yun Ling et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab
M. Kuwana et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Reduced Cd4(+)Cd25(+) T cells in patients with idiopathic thrombocytopenic purpura
Miho Sakakura et al.
THROMBOSIS RESEARCH (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The effect of antiplatelet autoantibodies on megakaryocytopoiesis
R McMillan et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Antagonist anti-human CD40 antibody inhibits germinal center formation in cynomolgus monkeys
AF de Vos et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
B Olsson et al.
NATURE MEDICINE (2003)
The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura
H Chan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Genetic analysis of autoantibodies in idiopathic thrombocytopenic-purpura reveals evidence of clonal expansion and somatic mutation
JH Roark et al.
BLOOD (2002)
Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura
M Kuwana et al.
JOURNAL OF IMMUNOLOGY (2002)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura:: a randomised, multicentre trial
B Godeau et al.
LANCET (2002)
Share Paper
